zm 241385 has been researched along with psb 1115 in 3 studies
Studies (zm 241385) | Trials (zm 241385) | Recent Studies (post-2010) (zm 241385) | Studies (psb 1115) | Trials (psb 1115) | Recent Studies (post-2010) (psb 1115) |
---|---|---|---|---|---|
401 | 3 | 124 | 11 | 0 | 7 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Azuaje, J; Carbajales, C; Crespo, A; El Maatougui, A; Escalante, L; García-Mera, X; González-Gómez, M; Gutiérrez-de-Terán, H; Miguez, G; Sotelo, E | 1 |
Azuaje, J; Brea, J; Cadavid, MI; Carbajales, C; García-Mera, X; Gutiérrez-de-Terán, H; Loza, MI; Masaguer, CF; Oliveira, A; Sotelo, E | 1 |
Alispahic, B; Åqvist, J; Azuaje, J; Brea, J; Caamaño, O; Crespo, A; El Maatougui, A; Fernandez-Masaguer, C; Freire-Garabal, M; García-Mera, X; Garcia-Santiago, C; Gioé, C; Gutiérrez-de-Terán, H; Jespers, W; Loza, MI; Majellaro, M; Mallo-Abreu, A; Novio, S; Núñez, MJ; Prieto-Díaz, R; Rodríguez-García, C; Sardina, JF; Sotelo, E; Stefanachi, A | 1 |
3 other study(ies) available for zm 241385 and psb 1115
Article | Year |
---|---|
Discovery of Potent and Highly Selective A2B Adenosine Receptor Antagonist Chemotypes.
Topics: Adenosine A2 Receptor Antagonists; Dose-Response Relationship, Drug; Drug Discovery; Humans; Models, Molecular; Molecular Structure; Pyrimidinones; Receptor, Adenosine A2B; Structure-Activity Relationship | 2016 |
Enantiospecific Recognition at the A
Topics: Carbon-13 Magnetic Resonance Spectroscopy; Proton Magnetic Resonance Spectroscopy; Pyrimidines; Receptor, Adenosine A2B; Spectrometry, Mass, Electrospray Ionization; Stereoisomerism | 2017 |
3,4-Dihydropyrimidin-2(1
Topics: Adenosine A2 Receptor Antagonists; Animals; CHO Cells; Cricetulus; Cyclic AMP; HEK293 Cells; HeLa Cells; Humans; Models, Molecular; Neoplasm Metastasis; Pyrimidines; Radioligand Assay; Receptor, Adenosine A2B; Stereoisomerism; Structure-Activity Relationship | 2021 |